Reuters logo
BRIEF-Evolva sells EV-035 series to Emergent Biosolutions
December 17, 2014 / 7:07 AM / 3 years ago

BRIEF-Evolva sells EV-035 series to Emergent Biosolutions

Dec 17 (Reuters) - Evolva Holding SA :

* Sells EV-035 series to emergent biosolutions

* Announced that Emergent Biosolutions Inc. has acquired Evolva’s anti-bacterial programme, EV-035 series

* For Evolva, this transaction is worth up to $70.5 million plus royalties Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below